Inactivation of HAUSP in vivo modulates p53 function.
Open accessAbstract
Hausp is a deubiquitinase that has been shown to regulate the p53-Mdm2 pathway. Cotransfection of p53 and Hausp stabilizes p53 through the removal of ubiquitin moieties from polyubiquitinated p53. Interestingly, knockout or RNA interference-mediated knockdown of Hausp in human cells also resulted in the stabilization of p53 due to the destabilization of Mdm2, suggesting a dynamic role of Hausp in p53 activation. To understand the physiological functions of Hausp, we generated hausp knockout mice. Hausp knockout mice die during early embryonic development between embryonic days E6.5 and E7.5. The hausp knockout embryos showed p53 activation, but no apparent increase in apoptosis. Embryonic lethality was caused by a dramatic reduction in proliferation and termination in development, in part due to p53 activation and/or abrogation of p53-independent functions. Although deletion of p53 did not completely rescue the embryonic lethality of the hausp knockout, embryonic development was extended in both hausp and p53 double knockout embryos. These data show that Hausp has a critical role in regulating the p53-Mdm2 pathway.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Homozygous knockout of USP7 in mice results in early embryonic lethality.
“USP7 is an essential enzyme; its homozygous knockout in mice results is early embryonic lethality (Kon et al., 2010)”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Kon et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840 · see citing works
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984 · see citing works
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854 · see citing works
Defining the Human Deubiquitinating Enzyme Interaction Landscape
Sowa, M. E., Bennett, E. J., Gygi, S. P., & Harper, J. W. (2009) · Cell · doi:10.1016/j.cell.2009.04.042 · Cited by 1,512 · see citing works
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1× · see citing works
“However, combining a p53-null background with the mdm2 knockout rescues this phenotype, suggesting that Mdm2 is a major negative regulator of p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
Ubiquitin: structures, functions, mechanisms
Pickart, C. M., & Eddins, M. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.019 · Cited by 1,406 · see citing works
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 1× · see citing works
“However, combining a p53-null background with the mdm2 knockout rescues this phenotype, suggesting that Mdm2 is a major negative regulator of p53 (Jones et al., 1995; Montes de Oca Luna et al., 1995).”
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. J. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,027 · see citing works
Chen, X., Ko, L. J., Jayaraman, L., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.19.2438 · Cited by 735 · see citing works
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 717 · see citing works
The ubiquitin ligase COP1 is a critical negative regulator of p53
Dornan, D., Wertz, I. E., Shimizu, H., Arnott, D. P., Frantz, G. D., Dowd, P., Rourke, K. O., Koeppen, H., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02514 · Cited by 700 · see citing works
A dynamic role of HAUSP in the p53-Mdm2 pathway
Li, M., Brooks, C. L., Kon, N., & Gu, W. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00157-1 · Cited by 679 · see citing works
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654 · see citing works
Hu, M., Li, P., Li, M., Li, W., Yao, T., Wu, J.-W., Gu, W. J., Cohen, R. E., & Shi, Y. (2002) · Cell · doi:10.1016/s0092-8674(02)01199-6 · Cited by 648 · see citing works
ARF-BP1/Mule Is a Critical Mediator of the ARF Tumor Suppressor
Chen, D., Kon, N., Li, M., Zhang, W., Qin, J., & Gu, W. J. (2005) · Cell · doi:10.1016/j.cell.2005.03.037 · Cited by 539 · see citing works
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP
van der Horst, A., de Vries-Smits, A. M. M., Brenkman, A. B., van Triest, M. H., van den Broek, N. J. F., Colland, F., Maurice, M. M., & Burgering, B. M. T. (2006) · Nature Cell Biology · doi:10.1038/ncb1469 · Cited by 479 · see citing works
Substrate Targeting in the Ubiquitin System
Laney, J. D., & Hochstrasser, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80752-7 · Cited by 451 · see citing works
Disruption of HAUSP gene stabilizes p53.
Cummins, J. M., Rago, C., Kohli, M., Kinzler, K. W., Lengauer, C., & Vogelstein, B. (2004) · Nature · doi:10.1038/nature02501 · Cited by 379 · see citing works
Babu, J. R., Jeganathan, K. B., Baker, D. J., Wu, X., Kang, N., & van Deursen, J. M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211048 · Cited by 342 · see citing works
Meulmeester, E., Maurice, M. M., Boutell, C., Teunisse, A. F. A. S., Ovaa, H., Abraham, T. E., Dirks, R. W., & Jochemsen, A. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.024 · Cited by 260 · see citing works
GMP Synthetase Stimulates Histone H2B Deubiquitylation by the Epigenetic Silencer USP7
van der Knaap, J. A., Kumar, B. R. P., Moshkin, Y. M., Langenberg, K. P. S., Krijgsveld, J., Heck, A. J. R., Karch, F., & Verrijzer, C. P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.013 · Cited by 258 · see citing works
Hu, M., Gu, L., Li, M., Jeffrey, P. D., Gu, W., & Shi, Y. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040027 · Cited by 251 · see citing works
Critical role for Daxx in regulating Mdm2
Tang, J., Qu, L., Zhang, J., Wang, W., Michaelson, J. S., Degenhardt, Y., El‐Deiry, W. S., & Yang, X. (2006) · Nature Cell Biology · doi:10.1038/ncb1442 · Cited by 239 · see citing works
Niendorf, S., Oksche, A., Kisser, A., Löhler, J., Prinz, M., Schorle, H., Feller, S. M., Lewitzky, M., Horak, I. D., & Knobeloch, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01566-06 · Cited by 201 · see citing works
Analysis of the Deubiquitinating Enzymes of the Yeast Saccharomyces cerevisiae
Amerik, A. Y., Li, S., & Hochstrasser, M. (2000) · Biological Chemistry · doi:10.1515/bc.2000.121 · Cited by 187 · see citing works
Protein Interaction Domains of the Ubiquitin-specific Protease, USP7/HAUSP
Holowaty, M. N., Sheng, Y., Nguyen, T., Arrowsmith, C. H., & Frappier, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307200200 · Cited by 182 · see citing works
Wu, X., Kasper, L. H., Mantcheva, R. T., Mantchev, G. T., Springett, M. J., & van Deursen, J. M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051631598 · Cited by 144 · see citing works
Everett, R. D., Meredith, M., & Orr, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.417-426.1999 · Cited by 122 · see citing works
Mori, S., Ito, G., Usami, N., Yoshioka, H., Ueda, Y., Kodama, Y., Takahashi, M., Fong, K. M., Shimokata, K., & Sekido, Y. (2004) · Cancer · doi:10.1002/cncr.20164 · Cited by 76 · see citing works
USP7, a ubiquitin-specific protease, interacts with ataxin-1, the SCA1 gene product.
Hong, S.-H., Kim, S.-J., Ka, S., Choi, I., & Kang, S. (2002) · Molecular and cellular neurosciences · doi:10.1006/mcne.2002.1103 · Cited by 71 · see citing works
A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.
Becker, K., Marchenko, N., Palacios, G., & Moll, U. M. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5756 · Cited by 63 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · see citing works
Chauhan, D., Tian, Z., Nicholson, B., Kumar, K. G. S., Zhou, B., Carrasco, R., McDermott, J. L., Leach, C. A., Fulcinniti, M., Kodrasov, M. P., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.007 · Cited by 589 · see citing works
p53 post-translational modification: deregulated in tumorigenesis
Dai, C., & Gu, W. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.09.002 · Cited by 523 · see citing works
Deubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V., Rodrı́guez, D., Freije, J. M. P., & López-Otı́n, C. (2011) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 453 · see citing works
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Vucic, D., Dixit, V. M., & Wertz, I. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3143 · Cited by 451 · see citing works
Deubiquitylases From Genes to Organism
Clague, M. J., Barsukov, I., Coulson, J. M., Liu, H., Rigden, D. J., & Urbé, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00002.2013 · Cited by 422 · see citing works
p53 modifications: exquisite decorations of the powerful guardian
Liu, Y., Tavana, O., & Gu, W. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz060 · Cited by 392 · see citing works
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
Wang, L., Wu, C., Rajasekaran, N., & Shin, Y. K. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495956 · Cited by 334 · see citing works
USP7 small-molecule inhibitors interfere with ubiquitin binding.
Kategaya, L., Di Lello, P., Rougé, L., Pastor, R., Clark, K. R., Drummond, J., Kleinheinz, T., Lin, E., Upton, J.-P., Prakash, S., et al. (2017) · Nature · doi:10.1038/nature24006 · Cited by 333 · see citing works
Faesen, A. C., Dirac, A. M. G., Shanmugham, A., Ovaa, H., Anastassis Perrakis, A., & Sixma, T. K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.034 · Cited by 251 · see citing works
USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses
Zou, Q., Jin, J., Hu, H., Li, H. S., Romano, S., Xiao, Y., Nakaya, M., Zhou, X., Cheng, X., Yang, P., et al. (2014) · Nature Immunology · doi:10.1038/ni.2885 · Cited by 248 · see citing works
The Multifaceted Roles of USP7: New Therapeutic Opportunities
Nicholson, B., & Kumar, S. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9185-5 · Cited by 243 · see citing works
Discovery and characterization of highly potent and selective allosteric USP7 inhibitors
Gavory, G., O'Dowd, C. R., Helm, M. D., Flasz, J., Arkoudis, E., Dossang, A., Hughes, C., Cassidy, E., McClelland, K., Odrzywol, E., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2528 · Cited by 224 · see citing works
Hao, Y.-H., Fountain, M. D., Fon Tacer, K., Xia, F., Bi, W., Kang, S.-H. L., Patel, A., Rosenfeld, J. A., Le Caignec, C., Isidor, B., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.033 · Cited by 206 · see citing works
HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma
Tavana, O., Li, D., Dai, C., López, G., Banerjee, D., Kon, N., Chen, C., Califano, A., Yamashiro, D. J., Sun, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4180 · Cited by 202 · see citing works
USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.
Fan, Y.-H., Cheng, J., Vasudevan, S. A., Dou, J., Zhang, H., Patel, R. H., Ma, I. T., Rojas, Y., Zhao, Y., Yu, Y., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.400 · Cited by 199 · see citing works
Felle, M., Joppien, S., Németh, A., Diermeier, S. D., Thalhammer, V., Dobner, T., Kremmer, E., Kappler, R., & Längst, G. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr528 · Cited by 198 · see citing works
Structure-guided development of a potent and selective non-covalent active-site inhibitor of USP7.
Lamberto, I., Liu, X., Seo, H.-S., Schauer, N. J., Iacob, R. E., Hu, W., Das, D., Mikhailova, T., Weisberg, E. L., Engen, J. R., et al. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.09.003 · Cited by 192 · see citing works
USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
Palazón‐Riquelme, P., Worboys, J. D., Green, J., Valera, A., Martín‐Sánchez, F., Pellegrini, C., Brough, D., & López‐Castejón, G. (2018) · EMBO Reports · doi:10.15252/embr.201744766 · Cited by 185 · see citing works
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186 · see citing works
Self-citationUSP7: Structure, substrate specificity, and inhibition
Pozhidaeva, A., & Bezsonova, I. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.02.005 · Cited by 178 · see citing works
The role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168 · see citing works
Limiting the power of p53 through the ubiquitin proteasome pathwayPreprint
Pant, V., & Lozano, G. (2014) · Genes & Development · doi:10.1101/gad.247452.114 · Cited by 165 · see citing works
Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1
Qin, W., Leonhardt, H., & Spada, F. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22998 · Cited by 163 · see citing works
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases.
Bhattacharya, S., Chakraborty, D., Basu, M., & Ghosh, M. K. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0012-y · Cited by 162 · see citing works
Chao, C. C. ‐. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.08.015 · Cited by 152 · see citing works
Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
Antao, A. M., Tyagi, A., Kim, K.-S., & Ramakrishna, S. (2020) · Cancers · doi:10.3390/cancers12061579 · Cited by 150 · see citing works
USP7 is a SUMO deubiquitinase essential for DNA replication.
Lecona, E., Rodriguez-Acebes, S., Specks, J., Lopez-Contreras, A. J., Ruppen, I., Murga, M., Muñoz, J., Mendez, J., & Fernandez-Capetillo, O. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3185 · Cited by 148 · see citing works
Durcan, T. M., Kontogiannea, M., Thorarinsdottir, T., Fallon, L., Williams, A. J., Djarmati, A., Fantaneanu, T. A., Paulson, H. L., & Fon, E. A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq452 · Cited by 147 · see citing works
Deubiquitinases and the new therapeutic opportunities offered to cancer
Pfoh, R., Lacdao, I. K., & Saridakis, V. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0516 · Cited by 140 · see citing works
Wang, Z., Kang, W.-T., Li, O., Qi, F., Wang, J., You, Y., He, P., Suo, Z., Zheng, Y., & Liu, H. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.005 · Cited by 139 · see citing works
Nucleotide Biosynthetic Enzyme GMP Synthase Is a TRIM21-Controlled Relay of p53 Stabilization
Reddy, B. A., van der Knaap, J. A., Bot, A. G. M., Mohd-Sarip, A., Dekkers, D. H. W., Timmermans, M. A. M., Martens, J. W. M., Demmers, J., & Verrijzer, C. P. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.017 · Cited by 131 · see citing works
Attenuating the p53 Pathway in Human Cancers: Many Means to the Same EndPreprint
Wasylishen, A. R., & Lozano, G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026211 · Cited by 128 · see citing works
Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade
Wang, Y., Jiang, Y., Ding, S., Li, J., Song, N., Ren, Y., Hong, D., Wu, C., Li, B., Wang, F., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0091-x · Cited by 128 · see citing works
USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin
Ji, L., Lu, B., Zamponi, R., Charlat, O., Aversa, R. J., Yang, Z., Sigoillot, F. D., Zhu, X., Hu, T., Reece-Hoyes, J. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12143-3 · Cited by 129 · see citing works
Wu, H.-T., Kuo, Y.-C., Hung, J.-J., Huang, C.-H., Chen, W.-Y., Chou, T.-Y., Chen, Y., Chen, Y.-J., Chen, Y.-J., Cheng, W.-C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13644 · Cited by 129 · see citing works
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114 · see citing works
“Telomeres are protein-nucleotide structures at the termini of each eukaryotic chromosome, which in humans contain 10 to 15 kb of a repeating hexanucleotide sequence (Kong et al., 2013).”
BackgroundTSPYL5 suppresses p53 levels and function by physical interaction with USP7.
Epping, M. T., Meijer, L. A. T., Krijgsman, O., Bos, J. L., Pandolfi, P. P., & Bernards, R. (2011) · Nature Cell Biology · doi:10.1038/ncb2142 · Cited by 117 · see citing works
Role of the nucleus in apoptosis: signaling and execution
Prokhorova, E. A., Zamaraev, A. V., Kopeina, G. S., Zhivotovsky, B., & Lavrik, I. N. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2031-y · Cited by 115 · see citing works
DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization
Papp, S. J., Huber, A., Jordan, S. D., Kriebs, A., Nguyen, M., Moresco, J. J., Yates, J. R., & Lamia, K. A. (2015) · eLife · doi:10.7554/elife.04883 · Cited by 113 · see citing works
Mdm2 and MdmX partner to regulate p53
Wang, X., & Jiang, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.049 · Cited by 111 · see citing works
Modulation of the p53/MDM2 interplay by HAUSP inhibitors
Tavana, O., & Gu, W. J. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw049 · Cited by 108 · see citing works
Yang, W.-L., Zhang, X., & Lin, H.-K. (2010) · Oncogene · doi:10.1038/onc.2010.190 · Cited by 101 · see citing works
Regulation of USP7: A High Incidence of E3 Complexes
Kim, R. Q., & Sixma, T. K. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.05.028 · Cited by 96 · see citing works
Usp7 regulates Hippo pathway through deubiquitinating the transcriptional coactivator Yorkie
Sun, X., Ding, Y., Zhan, M., Li, Y., Gao, D., Wang, G., Gao, Y., Li, Y., Wu, S., Lu, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08334-7 · Cited by 94 · see citing works
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia
Jin, Q., Martinez, C. A., Arcipowski, K. M., Zhu, Y., Gutierrez-Diaz, B. T., Wang, K. K., Johnson, M. R., Volk, A. G., Wang, F., Wu, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1740 · Cited by 95 · see citing works
Ma, P., Yang, X., Kong, Q., Li, C., Yang, S., Li, Y., & Mao, B. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00731-14 · Cited by 93 · see citing works
Deubiquitination of Ci/Gli by Usp7/HAUSP Regulates Hedgehog Signaling
Zhou, Z., Yao, X., Li, S., Xiong, Y., Dong, X., Zhao, Y., Jiang, J., & Zhang, Q. H. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.05.016 · Cited by 88 · see citing works
Roles of HAUSP-mediated p53 regulation in central nervous system development
Kon, N., Zhong, J., Kobayashi, Y., Li, M., Szabolcs, M., Ludwig, T., Canoll, P. D., & Gu, W. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2011.12 · Cited by 79 · see citing works
WDR20 Regulates Activity of the USP12·UAF1 Deubiquitinating Enzyme Complex
Kee, Y., Yang, K., Cohn, M. A., Haas, W., Gygi, S. P., & D’Andrea, A. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095141 · Cited by 85 · see citing works
Zhao, G., Lin, Z., Lu, C., Gu, J., Yuan, Y., Xu, F., Liu, R., Ge, D., & Ding, J. (2014) · Tumor Biology · doi:10.1007/s13277-014-2773-4 · Cited by 84 · see citing works
Deubiquitination of Tip60 by USP7 determines the activity of the p53-dependent apoptotic pathway.
Dar, A., Shibata, E., & Dutta, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-13 · Cited by 83 · see citing works
Cellular and disease functions of the Prader–Willi Syndrome gene<i>MAGEL2</i>
Tacer, K. F., & Potts, P. R. (2017) · Biochemical Journal · doi:10.1042/bcj20160616 · Cited by 81 · see citing works
Reiner, T., Parrondo, R. D., Pozas, A. D. L., Palenzuela, D. L., & Perez‐Stable, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056234 · Cited by 77 · see citing works
Morra, F., Merolla, F., Napolitano, V., Ilardi, G., Miro, C., Paladino, S., Staibano, S., Cerrato, A., & Celetti, A. (2017) · Oncotarget · doi:10.18632/oncotarget.16463 · Cited by 74 · see citing works
Functional analysis of deubiquitylating enzymes in tumorigenesis and development
Cheng, J., Guo, J., North, B. J., Wang, B., Cui, C., Li, H., Tao, K., Zhang, L., & Wei, W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188312 · Cited by 74 · see citing works
Lv, L., Xiao, X., Gu, Z., Zeng, F., Huang, L., & Jiang, G. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0585-4 · Cited by 72 · see citing works
Chen, S.-T., Okada, M., Nakato, R., Izumi, K., Bando, M., & Shirahige, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628255 · Cited by 69 · see citing works
Regulation of the p53 pathway by ubiquitin and related proteins
Hock, A., & Vousden, K. H. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.011 · Cited by 69 · see citing works
Yi, J., Li, H., Chu, B., Kon, N., Hu, X., Hu, J., Xiong, Y., Kanıskan, H. Ü., Jin, J. J., & Gu, W. J. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01180-7 · Cited by 69 · see citing works
Wei, R., Liu, X., Yu, W., Yang, T., Cai, W., Liu, J., Huang, X. S., Xu, G., Zhao, S., Yang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3671 · Cited by 69 · see citing works
Jiang, L., Xiong, J., Zhan, J., Yuan, F., Tang, M., Zhang, C., Cao, Z., Chen, Y., Lu, X., Li, Y., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780130 · Cited by 68 · see citing works
The role of UBL domains in ubiquitin-specific proteases
Faesen, A. C., Luna‐Vargas, M. P. A., & Sixma, T. K. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120004 · Cited by 66 · see citing works
Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells
Wei, X., Guo, J., Li, Q., Jia, Q., Jing, Q., Li, Y., Zhou, B., Chen, J., Gao, S., Zhang, X., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau7887 · Cited by 66 · see citing works
Giovinazzi, S., Morozov, V. M., Summers, M. K., Reinhold, W. C., & Ishov, A. M. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.169 · Cited by 65 · see citing works
Gao, Y., Koppen, A., Rakhshandehroo, M., Taşdelen, I., van de Graaf, S. F. J., van Loosdregt, J., van Beekum, O., Hamers, N., van Leenen, D., Berkers, C. R., et al. (2013) · Nature Communications · doi:10.1038/ncomms3656 · Cited by 65 · see citing works
USP7 Cooperates with SCML2 To Regulate the Activity of PRC1
Lecona, E., Narendra, V. K., & Reinberg, D. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01197-14 · Cited by 59 · see citing works
Ni, W., Lin, S., Bian, S., Zheng, W., Qu, L., Fan, Y., Lu, C., Xiao, M., & Zhou, P. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03075-8 · Cited by 59 · see citing works
Dual-utility NLS drives RNF169-dependent DNA damage responses
An, L., Jiang, Y., Ng, H. H. W., Man, E. P. S., Chen, J., Khoo, U., Gong, Q., & Huen, M. S. Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616602114 · Cited by 60 · see citing works
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival
He, Y., Wang, S., Tong, J., Jiang, S., Yang, Y., Zhang, Z., Xu, Y., Zeng, Y., Cao, B., Moran, M. F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010724 · Cited by 55 · see citing works
The USP7 protein interaction network and its roles in tumorigenesis
Al-Eidan, A., Wang, Y., Skipp, P., & Ewing, R. M. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2020.10.004 · Cited by 57 · see citing works
Peng, Y., Liu, Y., Gao, Y., Yuan, B., Qi, X., Fu, Y., Zhu, Q., Cao, T., Zhang, S., Yin, L., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1457-8 · Cited by 54 · see citing works
Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease
Rawat, R., Starczynowski, D. T., & Ntziachristos, P. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.02.008 · Cited by 53 · see citing works
Recent advances on the intervention sites targeting USP7-MDM2-p53 in cancer therapy
Harakandi, C., Nininahazwe, L., Xu, H., Liu, B., He, C., Zheng, Y., & Zhang, H. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105273 · Cited by 52 · see citing works
The role of deubiquitinating enzymes in cancer drug resistance
Tanguturi, P., Kim, K.-S., & Ramakrishna, S. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04046-8 · Cited by 49 · see citing works
Wertz, I. E., & Murray, J. M. (2019) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2019.02.003 · Cited by 48 · see citing works
Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?
López‐Castejón, G., & Edelmann, M. J. (2016) · Mediators of Inflammation · doi:10.1155/2016/3481371 · Cited by 48 · see citing works
Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors
Li, P., & Liu, H.-M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112107 · Cited by 48 · see citing works
Deubiquitylases in developmental ubiquitin signaling and congenital diseases
Basar, M. A., Beck, D. B., & Werner, A. A. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00697-5 · Cited by 44 · see citing works
Wu, J., Kumar, S., Wang, F., Wang, H., Chen, L., Arsenault, P., Mattern, M. R., & Weinstock, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00498 · Cited by 45 · see citing works
Li, J., Wang, R., Jin, J.-Y., Han, M., Chen, Z., Gao, Y., Hu, X., Zhu, H., Gao, H., Lu, K., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00188-4 · Cited by 44 · see citing works
HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response
Lim, K., Park, J.-J., Gu, B., Kim, J.-O., Park, S. G., & Baek, K. (2015) · Scientific Reports · doi:10.1038/srep12793 · Cited by 42 · see citing works
Fraile, J. M., Campos-Iglesias, D., Rodríguez, F. J., Español, Y., & Freije, J. M. P. (2016) · Oncotarget · doi:10.18632/oncotarget.12769 · Cited by 41 · see citing works
Ohol, Y. M., Sun, M. T., Cutler, G., Leger, P. R., Hu, D. X., Biannic, B., Rana, P., Cho, C., Jacobson, S., Wong, S., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0184 · Cited by 41 · see citing works
USP7 limits CDK1 activity throughout the cell cycle
Galarreta, A., Valledor, P., Ubieto‐Capella, P., Lafarga, V., Zarzuela, E., Muñoz, J., Malumbres, M., Lecona, E., & Fernández-Capetillo, Ó. (2021) · The EMBO Journal · doi:10.15252/embj.201899692 · Cited by 37 · see citing works
The toxic effect of aflatoxin B1 on early porcine embryonic development
Shin, K., Guo, J., Niu, Y., & Cui, X. (2018) · Theriogenology · doi:10.1016/j.theriogenology.2018.06.002 · Cited by 39 · see citing works
Targeting PTEN Regulation by Post Translational Modifications
González-Garcı́a, A., Garrido, A., & Carrera, A. C. (2022) · Cancers · doi:10.3390/cancers14225613 · Cited by 38 · see citing works
The equilibrium of tumor suppression: DUBs as active regulators of PTEN
Christine, A., Park, M. K., Song, S. J., & Song, M. S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00887-w · Cited by 41 · see citing works
Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1
Liang, L., Peng, Y., Zhang, J., Zhang, Y., Roy, M., Han, X., Xiao, X., Sun, S., Liu, H., Nie, L., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.206227 · Cited by 37 · see citing works
Dying to Survive—The p53 Paradox
Lees, A., Sessler, T., & McDade, S. S. (2021) · Cancers · doi:10.3390/cancers13133257 · Cited by 37 · see citing works
Deubiquitinases and cancer: A snapshot
Singh, N., & Singh, A. B. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.04.018 · Cited by 36 · see citing works
Targeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects
Khusbu, F. Y., Chen, F., & Chen, H. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3336 · Cited by 36 · see citing works
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia
Maat, H., Atsma, T. J., Hogeling, S. M., López, A. R., Jaques, J., Olthuis, M., de Vries, M. P., Gravesteijn, C., Brouwers-Vos, A. Z., van der Meer, N. K., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102435 · Cited by 36 · see citing works
Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma
Yu, Z., Wei, X., Liu, L., Sun, H., Fang, T., Wang, L., Li, Y., Sui, W., Wang, K., He, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103950 · Cited by 33 · see citing works
USP7 manipulation by viral proteins
Bojagora, A., & Saridakis, V. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198076 · Cited by 33 · see citing works
Molecular mechanisms and functions of cytokine-inducible deubiquitinating enzymes
Lim, K., Ramakrishna, S., & Baek, K. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.05.007 · Cited by 30 · see citing works
Sun, Y., Cao, L., Sheng, X., Chen, J., Zhou, Y., Yang, C., Deng, T., Ma, H., Feng, P., Liu, J., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.162 · Cited by 30 · see citing works
Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy
Pluciennik, A., Liu, Y., Molotsky, E., Marsh, G. B., Ranxhi, B., Arnold, F. J., St.-Cyr, S., Davidson, B. L., Pourshafie, N., Lieberman, A. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134565 · Cited by 30 · see citing works
Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance
Shin, S., Kim, C.-H., Jang, H.-R., & Yim, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228629 · Cited by 28 · see citing works
Zhu, S., Gu, H., Peng, C. Y., Xia, F., Cao, H., & Cui, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.849625 · Cited by 29 · see citing works
- Authors
- Kon, N., Kobayashi, Y., Li, M., Brooks, C. L., Ludwig, T., & Gu, W.
- Affiliations
- Columbia University (US)
- Venue
- Oncogene
- Published
- 2009-11-30
- Volume
- 29
- Issue
- 9
- Pages
- 1270-1279
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- PMC
- PMC2857765
- OpenAlex
- W2037667982
- Cited by
- 176
- References
- 31
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 28 · 2019: 14 · 2018: 15 · 2017: 15 · 2016: 10 · 2015: 10 · 2014: 8 · 2013: 10 · 2012: 8
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (P01CA097403, R01CA129627)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- USP7, p53, MDM2, deubiquitinase, p53 stabilization, MDM2-p53 pathway, embryonic lethality, cell proliferation, knockout mice, p53-independent function, apoptosis
- MeSH terms
- Ubiquitin-Specific Peptidase 7, Animals, Female, HeLa Cells, Humans, Substrate Specificity, Genes, p53, Tumor Suppressor Protein p53, Apoptosis, Mice, Knockout, Tumor Suppressor Proteins, Ubiquitin, RNA Interference, RNA, Small Interfering, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
